XSHE
000953
Market cap324mUSD
Oct 09, Last price
5.95CNY
1D
0.17%
1Q
12.48%
Jan 2017
-64.37%
Name
Guangxi Hechi Chemical Co Ltd
Chart & performance
P/E
333.86
P/S
12.12
EPS
0.02
Div yield, %
—
Shrs. gr., 5y
1.83%
Rev. gr., 5y
2.06%
Revenues
180m
-15.05%
Net income
7m
-91.77%
CFO
52m
P
Dividend
May 27, 20030.06 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Guangxi Chisage Fine Chemical Technology Co., Ltd. engages in the production and sale of chemical products. The company products include urea, compound fertilizers and pesticides, liquid carbon dioxide, formic acid, ammonium sulfate, pharmaceutical intermediates, food additives, plant extracts and chemical raw materials. It also engages in the research, development and promotion of biotechnology.
Key people
Yongzhang Lu
Chief Financial Officer · since 2020
Wenfu Wei
Deputy General Manager, Director · since 2006
Weiguang Yang
Deputy General Manager · since 2017
Honggao Tan
Secretary of the Board · since 2025
Weizhong Fang
Deputy General Manager, Director · since 2013
Luben Jiang
General Manager, Director · since 2024
Weiguang Shi
Director · since 2023
Baoming Tan
Director · since 2024
Xiaofeng Wang
Director · since 2023
Hai Wang
Director · since 2020
Yixue Wei
Vice Chairman of the Board · since 2024
Yihao Guo
Independent Director · since 2023
Independent Director · since 2025
Youbing Xue
Independent Director
Zaibo Yang
Independent Director · since 2025
Independent Director · since 2025
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||